Monitoring of BCR-ABL levels in chronic myeloid leukemia patients treated with imatinib in the chronic phase - the importance of a major molecular response
Published in
Revista Brasileira de Hematologia e Hemoterapia, January 2011
Pharmacology, Toxicology and Pharmaceutical Science
4
8%
Nursing and Health Professions
2
4%
Other
3
6%
Unknown
11
21%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2023.
All research outputs
#16,932,681
of 27,778,980 outputs
Outputs from Revista Brasileira de Hematologia e Hemoterapia
#30
of 83 outputs
Outputs of similar age
#160,892
of 203,550 outputs
Outputs of similar age from Revista Brasileira de Hematologia e Hemoterapia
#9
of 20 outputs
Altmetric has tracked 27,778,980 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 83 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.9. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 203,550 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.